At 4 o'clock in the afternoon of the next day, in the No. 6 conference hall of the Shenhai New Jin Jiang Hotel, the press conference was held on time. Pen "Fun" Pavilion www.biquge.info

The news media of the entire Shenhai heard the news, and Shenhai Satellite TV also specially filmed a broadcast team, although it was too late to arrange a live broadcast, but it is said that it will also be put in the evening news as a headline.

The print media were also on the lookout, and the print and photojournalists cooperated with each other and arrived early in the sixth room in order to get a more ideal position.

The five supports that Zhang Shi had made an appointment with were pre-occupied in the front seats through the 'back door' on the morning of the same day.

As soon as four o'clock arrived, Zhu Xiaojun walked into the reception with Daniel Feng Hu and walked straight to the rostrum of the No. 6 conference hall. Zhang Shi, as the host of the reception, first said some polite words, and then handed the microphone to Feng Hu.

According to the process, Feng Hu should introduce the process of his project.

However, Feng Hu just smiled and handed the microphone to Daniel instead.

Daniel took the microphone, shrugged his shoulders, and said only one sentence: "I'm just a validator for the research topic of specific antigens in lung cancer tissues, and I haven't been involved in previous studies, so I don't have much say." ”

The microphone was once again handed over to Feng Hu's hands.

"I'm an academic, and I don't know how to speak, and I don't know what journalist friends are most concerned about, so I'll just say a few words, anyway, there will be a question session later."

Then, Feng Hu objectively stated how Zhu Xiaojun was summoned, how he led the scientific research team to conduct experiments again and again in the transformation center, and why he went to the United States to publish scientific research results.

In the past half a month, Zhang Shi has deliberately leaked the content stated by Feng Hu through various channels, and various media have also published this information, but today, after being confirmed by the person concerned, the reporters still feel touched.

In particular, the person concerned personally confirmed that the scientific research team was indeed forced to go to the United States to release the results because of the helplessness of running into a wall in front of the health authorities.

This point made the reporters feel incredible and a little indignant.

At this time, Zhang Shi duly pushed the reception into the second link, and the reporter began to ask questions.

"I'm a reporter from the Shenhai Evening News, and I want to ask Dr. Feng and Daniel a question each. Dr. Feng, first of all, please forgive me for my ignorance of medicine, but I know that tumor-specific antigens are a blank in the world, and you have made a breakthrough in lung cancer, so which disease will you focus on next? The second question is, as a member of the American Academy of Medicine, Mr. Daniel, could you please make an objective evaluation of Dr. Feng's research results? ”

Feng Hu took the lead in answering: "There is a great deal of contingency in scientific research, especially in medicine, and this contingency is even more prominent. There are many, many medical scientists around the world who are engaged in the study of tumor-specific antigens, and most of them are better than me, but they are much worse in luck, and it is like walking a maze, with countless forks in the road and even more forks in the road for them to choose. And I, under the guidance of my boss, never made a detour, which led to the success of lung cancer-specific antigens. What I mean by this is that I don't know which disease to do next, I have to ask my boss, and without his guidance, I can't move an inch. ”

"Your boss? I beg your pardon for having one more question. The reporter from the Shenhai Evening News was obviously attracted: "Your boss, do you mean academic or commercial?" ”

Feng Hu smiled faintly and replied, "It is both academic and commercial. ”

The reporter's eyes couldn't help but fall on Zhu Xiaojun.

Everyone knows that Feng Hu's scientific research unit belongs to Qijiang Medical, and the big boss of Qijiang Medical is this unremarkable young man named Zhu Xiaojun sitting on the side of the rostrum.

He? Could it be Feng Hu's academic boss?

Surprised, not only the reporter who belonged to this Shenhai Daily, but all the reporters present, including the five trustees invited by Zhang Shi, were also full of surprise.

The reception scene suddenly fell into a chaotic whisper.

Feng Hu's words also surprised Zhu Xiaojun's expectations, when preparing for this reception, Zhu Xiaojun only explained Feng Hu's four words, telling the truth.

Only a statement that does not mess with any moisture is the most tenable argument, and Zhu Xiaojun is worried that Feng Hu's adaptability is not so good, so he did not plan to let Feng Hu talk more at the reception.

But unexpectedly, Feng Hu really told the truth and explained Zhu Xiaojun.

Zhu Xiaojun has no dislike for this episode, and it is undoubtedly a very pleasant thing to be able to be so low-key in the academic world, but if the emotions of the reporters are brought in this direction, it will inevitably have a great impact on the realization of Zhu Xiaojun's goal.

Zhu Xiaojun was not carried away by vanity, he hurriedly glanced at Daniel.

"The reason why malignant tumor is an incurable disease, the most critical point is that we human beings are not so clear about the pathogenesis of malignant tumors, the course of the disease and many other factors, decades ago, we thought that malignant tumors are only a local lesion, but now, we can be sure that malignant tumors are not a local problem, so no matter how thorough the operation, it just changed the evolution process of malignant tumors."

Daniel got Zhu Xiaojun's hint in his eyes, understood it, and immediately picked up the microphone and talked endlessly.

"Over the past 50 years, my country has spent a lot of effort and effort on a combination of surgery, chemotherapy and radiotherapy, but the results are very frustrating, and we don't think that these traditional treatments can cure malignant tumors. In recent years, the medical academic circles represented by the United States and Europe have begun to focus on the treatment of malignant tumors in immunology, such as the treatment of immune cells. ”

Speaking of this, Daniel deliberately glanced at Zhu Xiaojun.

Zhu Xiaojun nodded slightly at Daniel.

Acquiescing, Daniel continued with the prepared wording.

"More than 10 years ago, several medical scientists in the United States studied CIK cells, which were used in clinical practice and achieved unexpectedly excellent results, especially in melanoma, and achieved the clinical effect of complete remission of cancer with CIK treatment alone."